Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 234

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials

Open access
Piccolo, Raffaele, Bonaa, Kaare H, Efthimiou, Orestis, Varenne, Olivier, Baldo, Andrea, Urban, Philip, Kaiser, Christoph, Remkes, Wouter, Räber, Lorenz, de Belder, Adam, van 't Hof, Arnoud W J, Stankovic, Goran, Lemos, Pedro A, Wilsgaard, Tom, Reifart, Jörg, Rodriguez, Alfredo E, Ribeiro, Expedito E, Serruys, Patrick W J C, Abizaid, Alex, Sabaté, Manel, Byrne, Robert A, de la Torre Hernandez, Jose M, Wijns, William, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco, Piccolo, Raffaele, Bonaa, Kaare H., Efthimiou, Orestis, Varenne, Olivier, Baldo, Andrea, Urban, Philip, Kaiser, Christoph, Remkes, Wouter, Räber, Lorenz, de Belder, Adam, van't Hof, Arnoud W.J., Stankovic, Goran, Lemos, Pedro A., Wilsgaard, Tom, Reifart, Jörg, Rodriguez, Alfredo E., Ribeiro, Expedito E., Serruys, Patrick W.J.C., Abizaid, Alex, Sabaté, Manel, Byrne, Robert A., de la Torre Hernandez, Jose M., Wijns, William, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco · 2019 · The Lancet

Abstract

BACKGROUND New-generation drug-eluting stents (DES) have mostly been investigated in head-to-head non-inferiority trials against early-generation DES and have typically shown similar efficacy and superior safety. How the safety profile of new-generation DES compares with that of bare-metal stents (BMS) is less clear. METHODS We did an individual patient data meta-analysis of randomised clinical trials to compare outcomes after implantation of new-generation DES or BMS among patients undergoing percutaneous coronary intervention. The primary outcome was the composite of cardiac death or myocardial infarction. Data were pooled in a one-stage random-effects meta-analysis and examined at maximum follow-up and a 1-year landmark. Risk estimates are reported as hazard ratios (HRs) with 95% CIs. This study is registered in PROSPERO, number CRD42017060520. FINDINGS We obtained individual data for 26 616 patients in 20 randomised trials. Mean follow-up was 3·2 (SD 1·8) years. The risk of the primary outcome was reduced in DES recipients compared with BMS recipients (HR 0·84, 95% CI 0·78-0·90, p<0·001) owing to a reduced risk of myocardial infarction (0·79, 0·71-0·88, p<0·001) and a possible slight but non-significant cardiac mortality benefit (0·89, 0·78-1·01, p=0·075). All-cause death was unaffected (HR with DES 0·96, 95% CI 0·88-1·05, p=0·358), but risk was lowered for definite stent thrombosis (0·63, 0·50-0·80, p<0·001) and target-vessel revascularisation (0·55, 0·50-0·60, p<0·001). We saw a time-dependent treatment effect, with DES being associated with lower risk of the primary outcome than BMS up to 1 year after placement. While the effect was maintained in the longer term, there was no further divergence from BMS after 1 year. INTERPRETATION The performance of new-generation DES in the first year after implantation means that BMS should no longer be considered the gold standard for safety. Further development of DES technology should target improvements in clinical outcomes beyond 1 year. FUNDING Bern University Hospital.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(19)30474-x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 234

Metadata

Authors
Piccolo, R., Bonaa, K. H., Efthimiou, O., Varenne, O., Baldo, A., Urban, P., Kaiser, C., Remkes, W., Räber, L., de Belder, A., van 't Hof, A. W. J., Stankovic, G., Lemos, P. A., Wilsgaard, T., Reifart, J., Rodriguez, A. E., Ribeiro, E. E., Serruys, P. W. J. C., Abizaid, A., Sabaté, M., Byrne, R. A., de la Torre Hernandez, J. M., Wijns, W., Jüni, P., Windecker, S., Valgimigli, M., Piccolo, R., Bonaa, K. H., Efthimiou, O., Varenne, O., Baldo, A., Urban, P., Kaiser, C., Remkes, W., Räber, L., de Belder, A., van't Hof, A. W. J., Stankovic, G., Lemos, P. A., Wilsgaard, T., Reifart, J., Rodriguez, A. E., Ribeiro, E. E., Serruys, P. W. J. C., Abizaid, A., Sabaté, M., Byrne, R. A., de la Torre Hernandez, J. M., Wijns, W., Jüni, P., Windecker, S., & Valgimigli, M.
Venue
The Lancet
Publisher
Elsevier BV
Published
2019-06
Volume
393
Issue
10190
Pages
2503-2510
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2942545449
Cited by
234
References
6
FWCI
8.81
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. https://app.cochat.ai/papers/10.1016/s0140-6736(19)30474-x
The paper
Piccolo, R., Bonaa, K. H., Efthimiou, O., Varenne, O., Baldo, A., Urban, P., Kaiser, C., Remkes, W., Räber, L., de Belder, A., van 't Hof, A. W. J., Stankovic, G., Lemos, P. A., Wilsgaard, T., Reifart, J., Rodriguez, A. E., Ribeiro, E. E., Serruys, P. W. J. C., Abizaid, A., . . . Valgimigli, M. (2019). Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. The Lancet. https://doi.org/10.1016/s0140-6736(19)30474-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.